157 related articles for article (PubMed ID: 25941088)
1. Tracing differences between male and female breast cancer: both diseases own a different biology.
Kornegoor R; van Diest PJ; Buerger H; Korsching E
Histopathology; 2015 Dec; 67(6):888-97. PubMed ID: 25941088
[TBL] [Abstract][Full Text] [Related]
2. Hormone Receptor-Positive Breast Cancer Has a Worse Prognosis in Male Than in Female Patients.
Li X; Yang J; Krishnamurti U; Huo L; Ward KC; O'Regan R; Peng L
Clin Breast Cancer; 2017 Aug; 17(5):356-366. PubMed ID: 28576631
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of two androgen-induced markers (apolipoprotein D and pepsinogen C) in female and male breast carcinoma.
Serra C; Vizoso F; Lamelas ML; Rodríguez JC; González LO; Merino AM; Baltasar A; Pérez-Vázquez MT; Medrano J
Int J Surg Investig; 2000; 2(3):183-92. PubMed ID: 12678518
[TBL] [Abstract][Full Text] [Related]
4. [Analysis on the clinical and prognostic features of 71 male patients with breast cancer].
Liu DY; Xie GR; Chen M
Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Feb; 34(2):187-90. PubMed ID: 23751479
[TBL] [Abstract][Full Text] [Related]
5. Dachshund 1 is Differentially Expressed Between Male and Female Breast Cancer: A Matched Case-Control Study of Clinical Characteristics and Prognosis.
Cui Q; Kong D; Li Z; Ahiable P; Wang K; Wu K; Wu G
Clin Breast Cancer; 2018 Oct; 18(5):e875-e882. PubMed ID: 29478945
[TBL] [Abstract][Full Text] [Related]
6. A Prognostic Analysis of Male Breast Cancer (MBC) Compared with Post-Menopausal Female Breast Cancer (FBC).
Yu XF; Yang HJ; Yu Y; Zou DH; Miao LL
PLoS One; 2015; 10(8):e0136670. PubMed ID: 26313461
[TBL] [Abstract][Full Text] [Related]
7. Male breast cancer in the veterans affairs population: a comparative analysis.
Nahleh ZA; Srikantiah R; Safa M; Jazieh AR; Muhleman A; Komrokji R
Cancer; 2007 Apr; 109(8):1471-7. PubMed ID: 17342768
[TBL] [Abstract][Full Text] [Related]
8. Men and women show similar survival outcome in stage IV breast cancer.
Wu SG; Zhang WW; Liao XL; Sun JY; Li FY; Su JJ; He ZY
Breast; 2017 Aug; 34():115-121. PubMed ID: 28577471
[TBL] [Abstract][Full Text] [Related]
9. Molecular subtyping of male breast cancer using alternative definitions and its prognostic impact.
Nilsson C; Johansson I; Ahlin C; Thorstenson S; Amini RM; Holmqvist M; Bergkvist L; Hedenfalk I; Fjällskog ML
Acta Oncol; 2013 Jan; 52(1):102-9. PubMed ID: 22928693
[TBL] [Abstract][Full Text] [Related]
10. Lack of relationship between the expression of Hsp27 heat shock estrogen receptor-associated protein and estrogen receptor or progesterone receptor status in male breast carcinoma.
Muñoz de Toro MM; Luque EH
J Steroid Biochem Mol Biol; 1997 Mar; 60(5-6):277-84. PubMed ID: 9219918
[TBL] [Abstract][Full Text] [Related]
11. Prolactin receptor expression in gynaecomastia and male breast carcinoma.
Ferreira M; Mesquita M; Quaresma M; André S
Histopathology; 2008 Jul; 53(1):56-61. PubMed ID: 18613925
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic characteristics and prognosis for male breast cancer compared to female breast cancer.
Yao N; Shi W; Liu T; Siyin ST; Wang W; Duan N; Xu G; Qu J
Sci Rep; 2022 Jan; 12(1):220. PubMed ID: 34997151
[TBL] [Abstract][Full Text] [Related]
13. Poor prognosis of male triple-positive breast Cancer patients: a propensity score matched SEER analysis and molecular portraits.
Wang B; Wang H; Zhao A; Zhang M; Yang J
BMC Cancer; 2021 May; 21(1):523. PubMed ID: 33964913
[TBL] [Abstract][Full Text] [Related]
14. Proliferative activity and steroid hormone receptor status in male breast carcinoma.
Muñoz de Toro MM; Maffini MV; Kass L; Luque EH
J Steroid Biochem Mol Biol; 1998 Nov; 67(4):333-9. PubMed ID: 9883990
[TBL] [Abstract][Full Text] [Related]
15. Low-stage carcinoma of the male breast. A histologic, immunohistochemical, and flow cytometric comparison with localized female breast carcinoma.
Wick MR; Sayadi H; Ritter JH; Hill DA; Reddy VB; Gattuso P
Am J Clin Pathol; 1999 Jan; 111(1):59-69. PubMed ID: 9894455
[TBL] [Abstract][Full Text] [Related]
16. The biology of male breast cancer.
Fentiman IS
Breast; 2018 Apr; 38():132-135. PubMed ID: 29316513
[TBL] [Abstract][Full Text] [Related]
17. Intratumoral estrogen concentration and expression of estrogen-induced genes in male breast carcinoma: comparison with female breast carcinoma.
Takagi K; Moriya T; Kurosumi M; Oka K; Miki Y; Ebata A; Toshima T; Tsunekawa S; Takei H; Hirakawa H; Ishida T; Hayashi S; Kurebayashi J; Sasano H; Suzuki T
Horm Cancer; 2013 Feb; 4(1):1-11. PubMed ID: 23096432
[TBL] [Abstract][Full Text] [Related]
18. Chinese female breast cancer patients show a better overall survival than their male counterparts.
Xia LP; Zhou FF; Guo GF; Wang F; Wang X; Yuan ZY; Zhang B
Chin Med J (Engl); 2010 Sep; 123(17):2347-52. PubMed ID: 21034547
[TBL] [Abstract][Full Text] [Related]
19. Management of male breast cancer in the United States: a surveillance, epidemiology and end results analysis.
Fields EC; DeWitt P; Fisher CM; Rabinovitch R
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):747-52. PubMed ID: 24138917
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical study of androgen receptors in breast carcinoma. Evidence of their frequent expression in lobular carcinoma.
Riva C; Dainese E; Caprara G; Rocca PC; Massarelli G; Tot T; Capella C; Eusebi V
Virchows Arch; 2005 Oct; 447(4):695-700. PubMed ID: 16075292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
